Evidence map›Paper›PMID 40169511›Full record

ArticleStress biology2025

A fungal effector hijacks a plastid protein to dampen plant immunity; PR1 is here for rescue.

Muhammad Saad Shoaib Khan, Faisal Islam, Huan Chen, Jian Chen

Abstract readLetter
In one paragraph

Article in Stress biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Muhammad Saad Shoaib KhanInternational Genome Center, Jiangsu University, Zhenjiang, 212013, China.
Faisal IslamInternational Genome Center, Jiangsu University, Zhenjiang, 212013, China.
Huan ChenJoint Center of Single Cell Biology, School of Agriculture and Biology, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China. huan.chen@sjtu.edu.cn.
Jian ChenInternational Genome Center, Jiangsu University, Zhenjiang, 212013, China. jianchen@ujs.edu.cn.ORCID http://orcid.org/0000-0003-1694-8755

Funding

National Natural Science Foundation of China 32250410283National Natural Science Foundation of China 32250410314
6 · The paper itself

Abstract

Plants are engaged in a constant battle for survival against pathogens, which triggers a multifaceted immune response characterized by pattern-triggered immunity (PTI) and effector-triggered immunity (ETI) to prevent infection. These two immune responses operate synergistically to enhance plant immunity. PTI is considered the first line of defense involving the recognition of pathogen-associated molecular patterns (PAMPs) by specific receptors in host cells known as pattern recognition receptors (PRRs), which initiate defense signaling. However, many pathogens often overcome the first line of defense (PTI) and successfully deploy effector proteins to promote virulence and subvert plant immunity, leading to host susceptibility. In the counter-defense, the ETI defense mechanism is activated by triggering resistance (R) genes in plants that usually encode nucleotide-binding-leucine-rich-containing (NLR) proteins. During plant-pathogen interactions, transcriptional reprogramming of defense-related genes such as pathogenesis-related proteins and generation of reactive oxygen species (ROS) are essential for facilitating programmed cell death at the infected location to inhibit pathogen proliferation. While ROS and PR protein are critical in plant-pathogen interaction, they are not universally required or effective against all pathogens. Hence, plants' multilayer immune layer is encrypted with the compensatory activation of ETI defense response towards the failure of one component of the defense system to maintain robust immunity.

Identifiers

PMID40169511
PMCPMC11961826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.